Evidence map›Paper›PMID 17115136›Full record

ArticlePsychopharmacology2007

Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.

Janice W Smith, Adrian Mogg, Elisiana Tafi, Eleanor Peacey, Ian A Pullar, Philip Szekeres, Mark Tricklebank

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Evidence for AlphaThe Journal of pharmacology and experimental therapeutics · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evaluation of the cardiovascular effects of varenicline in rats.Drug design, development and therapy · 2015
    Article
  16. Article
  17. Article
  18. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  19. Methamphetamine-like discriminative-stimulus effects of nicotinic agonists.The Journal of pharmacology and experimental therapeutics · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Janice W SmithEli Lilly & Co Ltd, Lilly Research Centre, Sunninghill Road, Windlesham, Surrey, UK. Smith_Janice_W@lilly.com
Adrian Mogg
Elisiana Tafi
Eleanor Peacey
Ian A Pullar
Philip Szekeres
Mark Tricklebank
Eli Lilly (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleNicotine produces behavioural effects that are potentially related to its interaction with diverse nicotinic acetylcholine receptor populations. Evidence from gene deletion studies suggests that the interoceptive stimulus properties of nicotine are mediated by heteromeric high-affinity receptors containing alpha4beta2 subunits. Mice lacking beta2 subunits do not discriminate nicotine (Shoaib et al., Neuropharmacology, 42:530-539, 2002), and nicotine does not elicit dopamine release in these animals (Grady et al., J Neurochem, 76:258-268, 2001). The stimulus properties of nicotine can be detected in rats using a two-lever operant drug discrimination paradigm, allowing them to be classified pharmacologically using ligands with selectivity for receptors containing alpha4beta2, alpha3beta4 or alpha7 subunits. MATERIALS AND

methodsRats trained to discriminate 0.4 mg/kg nicotine from vehicle were given the nicotinic receptor agonists, cytisine, varenicline, TC2559, ABT-594, A-85380 (all having high affinity but varying selectivity for alpha4beta2-containing receptors), and WO 03/062224 and WO 01/60821A1 (selective for beta4- and alpha7-containing receptors, respectively). In separate studies, WO 03/062224 was used as the training stimulus.

resultsNicotine, TC-2559, A-85380 and ABT-594 showed dose-dependent and complete stimulus substitution, whilst WO 03/062224 and WO 01/60821A1 were completely without effect. Cytisine and varenicline showed partial generalisation, consistent with their partial agonist activity at nicotinic receptors eliciting dopamine release in rat striatal slices. After almost 50 training sessions with WO 03/062224, there was no clear evidence that an alpha3beta4 receptor agonist could sustain a discriminable stimulus.

conclusionSubstitution to the nicotine discriminative stimulus required high-affinity and high intrinsic activity at beta2 but not at beta4- or at alpha7-containing nicotinic receptors.

Indexed as

Motivationalpha7 Nicotinic Acetylcholine ReceptorAnimalsAppetitive BehaviorAzetidinesBenzazepinesCorpus StriatumCystineDiscrimination LearningDose-Response Relationship, DrugMaleNicotineNicotinic AgonistsPyridinesQuinoxalinesRats5-(2-azetidinylmethoxy)-2-chloropyridineA 85380alpha7 Nicotinic Acetylcholine ReceptorAzetidinesBenzazepinesChrna7 protein, mouseChrna7 protein, ratCystineNicotineNicotinic Agonistsnicotinic receptor alpha3beta4nicotinic receptor alpha4beta2PyridinesQuinoxalinesReceptors, NicotinicTC 2559Varenicline

Identifiers

PMID17115136
OpenAlexW1984644694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.